Catherine Cusack is Director at Sabra Health Care REIT, Inc. (SBRA). They have made 5 open-market trades across 1 company since 2021, most recently 2026-08-31.
CIK 0001838868
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $220K since 2021, never a sale. Across 5 scored buys the stock is up 4.6% at ninety days, and 1.5 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| SBRA | 82,847 | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-09-02 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 80% |
| Avg Move | +2.6% | +6.1% | +4.6% |
| Alpha | +3.5% | +4.8% | +1.5% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SBRA | BUY | 2025-02-21 | 2025-02-25 | $16.13 | $40K | +2.4% | +5.6% | +6.9% |
| SBRA | BUY | 2024-05-22 | 2024-05-23 | $14.43 | $101K | +0.7% | +4.5% | +13.3% |
| SBRA | BUY | 2022-02-25 | 2022-03-02 | $13.24 | $26K | +3.3% | +11.4% | +3.6% |
| SBRA | BUY | 2021-05-13 | 2021-05-17 | $17.19 | $34K | +2.0% | +3.8% | -5.1% |
| SBRA | BUY | 2021-03-02 | 2021-03-02 | $17.34 | $17K | +4.7% | +5.0% | +4.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.